Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 3 publications
A proteogenomic gene signature defines prognostic subgroups highlighting PI3K/AKT/mTOR signaling pathway as a therapeutic vulnerability in myeloid malignancies.
Journal: Cell communication and signaling : CCS
Published: August 30, 2025
TFEB degradation is regulated by an IKK/β-TrCP2 phosphorylation-ubiquitination cascade.
Journal: Nature communications
Published: October 19, 2023
Multiomic profiling reveals metabolic alterations mediating aberrant platelet activity and inflammation in myeloproliferative neoplasms.
Journal: The Journal of clinical investigation
Published: May 12, 2023
Showing 1-3 of 3
Last Updated: 09/26/2026